Metritis is a common postpartum reproductive disorder of dairy cows around the world, which leads to an increase in treatment cost, extension of the calving interval and decline in milk production. It seriously constrains the development of the dairy industry (9). Bacterial contamination of the postpartum uterus of dairy cows is inevitable (7). It is generally believed that postpartum metritis is caused by the entry into and proliferation in the uterus of conditional pathogens (4). The invasion of pathogens causes the body to actively mobilise immune factors to resist infection, for example by recruiting immune cells and cytokines to strengthen the inflammatory response.
Mast cells (MC) are activated and degranulated to release pre-storage medium histamine in cow metritis (24). A type I hypersensitivity reaction of mast cells occurs during metritis, and local inflammation can cause histamine excitation. The increase of histamine 2 receptor expression and the decrease of histamine 1 receptor expression inhibit the inflammatory response and prevent excessive damage to the uterine tissue. In addition to histamine, the pre-storage medium of mast cells also includes serotonin, tumour necrosis factor alpha (TNF)α and tryptase. Mast cells also synthesise and secrete leukotrienes, prostaglandins, platelet activating factors and other compounds (27). Leukotriene B4 (LTB4), as a powerful chemokine, can recruit immune cells such as neutrophils, macrophages and T cells to inflammatory sites and play an important role in a variety of acute and chronic inflammatory reactions (13, 19). However, its role in metritis is still unclear.
Mast cells are an important link between nerves and the immune system, which is closely related to the activity of neuropeptides. It was found that the neuropeptide substance P (SP) could promote the synthesis of LTB4 by mast cells by activating extracellular signal-regulated protein kinases 1 and 2 (17). Thermal, chemical and mechanical effects, bacteria and their secretions and other factors can cause changes in the potential on nerve endings and promote the opening of ion channels; calcium influx combines with vesicles, and SP is released after vesicles fuse with the cell membrane (14). Tryptase, as a pre-storage medium of mast cells, can promote the release of SP through protease-activated receptor-2 (PAR2) (16). Therefore, there is a positive feedback amplification effect between neuropeptide substance P (SP) and mast cells. The mutually promoting relationship between MC and SP is inhibited by the vasoactive intestinal peptide (VIP). The VIP neuropeptide can reduce organ damage by inhibiting mast cell degranulation (23). It can also inhibit the production of superoxide anion by monocytes and neutrophils and weaken the bactericidal activity (10).
The concentrations of inflammatory factors such as TNF-α, interleukin (IL)-1β, IL-6 and IL-8 increased significantly in cow metritis (6). Some of these cytokines came from mast cell degranulation and some from immune cells recruited by LTB4. The gene promoter position of matrix metalloproteinase (MMP)-9 exists in nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), activator protein 1, specificity protein 1 and other nuclear factor binding sites (1). Inflammatory factors can increase the expression of MMP-9 through these sites. Matrix metalloproteinase 9 participates in the activation of TNF-α (26). It can cleave IL-8 and enhance its chemotaxis at the specific site of the amino terminal (8). At the same time, inflammatory factors can enhance the synthesis and release of MMP-9 (21). Intact extracellular matrix molecules have no chemotaxis. When MMP-2 and MMP-9 degrade collagen in the extracellular matrix and form the proline-glycine-proline sequence, it can activate the CXC chemokine receptor 1/2 and lead to neutrophil chemotaxis (15). However, in the action of MMP-2 and MMP-9, the extracellular matrix in the basement membrane is degraded, the integrity of muscle fibres is destroyed, and inflammatory cells are immersed in muscle tissue, which may lead to a series of pathological inflammatory changes such as muscle fibre necrosis (5). Therefore, on the one hand, a small amount of collagenase is conducive to chemotaxis and promotes the activity of inflammatory factors, but on the other hand, excessive collagenase will cause tissue damage.
The LTB4 receptor (BLT) is divided into high-affinity receptor BLT1 and low-affinity receptor BLT2. The former is expressed on the upper surface of immune cells and can induce leukocyte proliferation and chemotaxis, and the latter is expressed in almost all tissues, inducing tissue cells to produce superoxide ions and strengthening the bactericidal effect. The low-affinity BLT2 is expressed on the vascular endothelium to produce vascular endothelial growth factor, and mast cells release IL-8 to induce vascular regeneration (11). Leukotriene B4 has a chemotactic action on fibroblasts, induces the synthesis of extracellular matrix proteins (22), and then participates in tissue remodelling. Therefore, the LTB4 receptors can enhance the infection fighting ability of uterine cells and participate in uterine remodelling, and may also cause tissue damage. However, it is unclear how LTB4 may affect the tissue structure of the endometrium in metritis. The expression of MMP-9 has not been reported in metritic uterine tissue.
This study took advantage of the postpartum metritis state in dairy cows to analyse the concentration changes of endometrial SP, VIP and LTB4 neuropeptides and detect the granular state of mast cells and the expression characteristics of the LTB4 receptor, collagen and collagenase. It discusses the SP-LTB4-MMP mechanism in postpartum metritis of dairy cows.
The primer sequences and PCR product length of the target genes
Gene/Accession number | Primer sequence | Fragment size (bp) |
---|---|---|
BLT2 | Forward 5′- TTCCTCATGCGGCTCTTT -3′ | |
NM_001191287 | Reverse 5′- CCCAACCCTGACTATCCTT -3′ | 163 bp |
MMP-2 | Forward 5′- AACGCCATCCCTGATAACC-3′ | |
NM_174745 | Reverse 5′- TCACGCTCTTCAGACTTTGGT-3′ | 115 bp |
MMP-9 | Forward 5′-GCCCATTAGCACGCACGAC-3′ | |
NM_174744 | Reverse 5′-GTAGCCCACATAGTCCACCTGA-3′ | 118 bp |
β-actin | Forward 5′-TCACCAACTGGGACGACA-3′ | |
NM_173979.3 | Reverse 5′-GCATACAGGGACAGCACA-3′ | 206 bp |
BLT2 – LTB4 receptor 2; MMP – matrix metalloproteinase
All the sections from different groups were processed simultaneously for immunohistochemistry. A gentle 0.01M phosphate-buffered saline solution (PBS; pH 7.2–7.4) was used to rinse between each step and the next. The steps were: incubation for 5 min in 3% hydrogen peroxide; 60 min in a blocking solution of 3% normal goat serum in PBS; overnight in primary antisera of types I and IV collagen (Boster Biological Technology, Wuhan, China) in blocking solution at 4℃; 30 min in diluted biotinylated species-specific anti-IG sera (Boster); and 20 min in streptavidin-biotin complex (Boster). Negative sections were incubated without primary antibodies. The sections were then stained for 4 min in 0.05% 3,3-diaminobenzidine tetrahydrochloride and 0.01% hydrogen peroxide. The reaction was halted by rinsing in cold PBS. The sections were counterstained with haematoxylin, dehydrated with alcohol, transparent with xylene and then coverslipped. Five sections spaced 500 μm apart were prepared from each group’s tissue samples.
Ultrastructure of endometrial
A – experimental group; B – control group (arrows indicate mast cell nuclei)
Substance P (SP), vasointestinal peptide (VIP) and leukotriene B4 (LTB4) concentrations in the endometrium
Parameter | Control group | Experimental group | P-value |
---|---|---|---|
SP, ng/mL | 308.12 ± 9.72 | 1258.06 ± 128.88* | P < 0.01 |
VIP, ng/mL | 1667.34 ± 153.40 | 615.73 ± 70.50* | P < 0.01 |
LTB4, pg/mL | 23.14 ± 1.12 | 78.84 ± 12.55* | P < 0.01 |
* – P < 0.01 for significant difference
Expression of leukotriene B4 receptor 2 (BLT2), matrix metalloproteinase (MMP)-2 and MMP-9 mRNA by real-time quantitative PCR
* – P < 0.05 for significant difference
Immunohistochemical analysis of types I and IV collagen in endometrium (iOD × 103, n = 10)
Group | Control | Experimental | P-value |
---|---|---|---|
Collagen Ⅰ | 2.216 ± 0. 432 | 1.568 ± 0. 342 | P < 0.05 |
Collagen Ⅳ | 1.946 ± 0. 365 | 1.493 ± 0.182 | P < 0.05 |
iOD – integrated option density
It is inevitable for bacteria to enter a cow’s uterus and proliferate after parturition. Bacteria and their secretions stimulate the release of SP from uterine nerve axon terminals. Substance P can activate mast cells and cause Ca2+ mobilisation and cell degranulation (12). After activation, the tryptase released by mast cells can bind with PAR2 on the nerve surface containing neuropeptides to promote the release of SP and other neuropeptides. There are other ways to promote mast cell degranulation, such as the IgE-dependent histamine release process (28). However, only SP does not need extracellular Ca2+, and only SP has a mutual amplification effect on mast cell degranulation and plays a role in a limited time (3). This study found that the concentration of SP in uterine tissue increased significantly in metritis, and promoted the degranulation of mast cells through the receptor independent pathway, which is consistent with the phenomenon of mast cell activation and degranulation. Mast cells release pre-stored mediators such as histamine and tryptase after activation. This is consistent with the finding of our previous study that mast cells are activated and degranulated to release histamine in metritis (24). In addition to SP content, the content of leukotriene B4 increased significantly in metritis, which is also the main new synthetic medium synthesised and released by mast cells after activation. Leukotriene B4 recruits leukocytes to fight infection with its powerful chemotactic function. The effect of neuropeptide VIP on mast cells is opposite to that of neuropeptide SP, which can inhibit mast cell degranulation and change the content of intracellular particles (20). This is primarily achieved by promoting the generation and accumulation of cyclic adenosine monophosphate. This study revealed that the concentration of neuropeptide VIP in the endometrium decreased significantly in metritis, indicating that its inhibitory effect on SP decreased. The weaker inhibitory effect resulted in excessive activation of mast cells, which is also related to the significant increase of LTB4 concentration. Although it is beneficial for the body to recruit immune cells to fight infection, it may also lead to excessive immunoactivity and histopathological damage.
In recent years, the importance of the regulatory effect of MMPs on inflammation has been recognised. Matrix metalloproteinases may not only affect the activity of some cytokines, but also continuously reshape the extracellular matrix, in order to facilitate the migration of immune cells to the disease site (25). Therefore, the roles of MMP-2 and MMP-9 in the inflammatory response must not be underestimated, and Opdenakker
In conclusion, bacteria and their secretions stimulate the release of neuropeptide SP from uterine nerve axon terminals. Significantly elevated SP promotes the activation of mast cells and the synthesis and release of LTB4 to recruit immune cells such as granulocytes. The uterine tissue expresses large amounts of collagenase MMP-2 and MMP-9, which promotes the hydrolysis of the extracellular matrix to facilitate the migration of immune cells to inflammatory sites. The low expression of the VIP neuropeptide weakened its inhibitory effect on mast cell activation and LTB4 synthesis. Thus, the overexpression of LTB4 may be closely related to the tissue damage in metritis.